Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9P5P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,596
Award facts
- Contract value 100% obligated
- $49,596.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $49,596.33 to AmerisourceBergen Drug Corp for the supply of Zepbound (semaglutide) 2.5 mg/0.5 mL pen injections on December 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award, and specifies a completion date of December 3, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for the Department of Defense.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's portfolio under the DLA IDC encompasses a broad range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This delivery order for Zepbound reflects the company's role in supplying medications to support military healthcare programs worldwide, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DR26F9P5P?
SPE2DR26F9P5P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9P5P worth?
The government has obligated $49,596 on SPE2DR26F9P5P.
Is contract SPE2DR26F9P5P an order under another contract?
Yes. SPE2DR26F9P5P is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P5P competed?
The extent of competition for SPE2DR26F9P5P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award